Trump plans generic drug tariffs from 2028 with two-year delay testing U.S. onshoring push
Headline as filed by CNBC Economy. PageNews does not write or rewrite headlines.
Coverage overview
One publisher, CNBC Economy, has reported this so far, at 06:28 UTC on 22 July 2026.
No other outlet PageNews follows has covered it. If one files, their report will be added to this page and the comparison below will fill out.
The coverage is filed under Economy. The publisher's own headline, summary and link is below.
Compiled by PageNews from the reports listed below. No publisher wrote this summary.
Original report
-
CNBC Economy
Trump plans generic drug tariffs from 2028 with two-year delay testing U.S. onshoring push
The latest tariff salvo underscored Trump's goal of reshoring low-cost drug production, but displacing established suppliers like India won't be easy.
Read on CNBC Economy →
